William Blair & Company
NDRA icon

William Blair & Company’s ENDRA Life Sciences NDRA Stock Holding History

William Blair & Company’s Portfolio NDRA Stock Details NDRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1
Closed -$61K – 2007
2021
Q3 		$61K Hold
1
– – ﹤0.01% 1667
2021
Q2 		$76K Hold
1
– – ﹤0.01% 1640
2021
Q1 		$91K Buy
+1
New +$74.9K ﹤0.01% 1606

Other funds holding NDRA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
5L
55I LLC Boston, Massachusetts $3.58B AUM 17.97% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

William Blair & Company's NDRA Position: Q4 2021 in Review

William Blair & Company sold out of ENDRA Life Sciences (NDRA) in Q4 2021, closing a stake of 1 share — an estimated $61K sold.

William Blair & Company first reported a position in NDRA in Q1 2021 and held it in 3 quarters. The position peaked at $91K in Q1 2021. 14 funds tracked by Wall St. Rank hold NDRA as of Q4 2021.

  • William Blair & Company reported no remaining ENDRA Life Sciences position as of Q4 2021 after selling out during the quarter.
  • William Blair & Company sold 1 ENDRA Life Sciences share in Q4 2021, an estimated $61K.
  • William Blair & Company first reported a position in ENDRA Life Sciences in Q1 2021 and held it in 3 quarters.
  • William Blair & Company's ENDRA Life Sciences position peaked at $91K in Q1 2021.
  • 14 funds tracked by Wall St. Rank held ENDRA Life Sciences as of Q4 2021.

Based on William Blair & Company's 13F filing for Q4 2021, filed 14 Feb 2022.